SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · RA Capital Management, L.P., a director and 10% owner of Artiva…

Artiva Biotherapeutics, Inc. · INSIDER-BUY filed Jul 14, 2026 at 19:00 ET

At the news

BULLISHIMPACT 5/10

INSIDER-BUY filed Jul 14, 2026 at 19:00 ET

RA Capital Management, L.P., a director and 10% owner of Artiva Biotherapeutics, purchased 15,100 shares at $8.97 for a total of $135K on July 10, 2026. This is a standalone conviction buy by a major insider, signaling confidence in the company's prospects at current valuation.

  • RA Capital Management (Director, 10% Owner) bought 15,100 shares at $8.97 for $135K on July 10, 2026.
  • Total purchase value of $135K represents approximately 0.06% of Artiva's $221M market cap.
  • Recent insider activity shows 6 buys totaling $1.7M in the last 30 days, indicating sustained insider confidence.
  • Analyst consensus is 92% bullish (4 Strong Buy, 7 Buy, 1 Hold).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access